Yes, there is medication for body dysmorphic disorder (BDD), and it works for the majority of people who try it. A class of antidepressants called SSRIs is the first-line pharmaceutical treatment, with response rates between 53% and 73% across clinical studies. No medication currently has FDA approval specifically for BDD, but several SSRIs are widely prescribed off-label based on strong clinical evidence.
Which Medications Are Used
SSRIs, short for selective serotonin reuptake inhibitors, are the go-to medications for BDD. These are the same drugs commonly prescribed for depression and OCD, but they work on BDD through a related mechanism: they reduce the obsessional thinking and compulsive behaviors that drive the condition. When someone with BDD improves on an SSRI, brain imaging research shows that previously abnormal activity patterns normalize.
Several SSRIs have been studied for BDD specifically:
- Fluoxetine (Prozac) showed a 53% response rate in a placebo-controlled trial, compared to 18% for placebo.
- Citalopram (Celexa) and escitalopram (Lexapro) each showed 73% response rates in open-label trials.
- Fluvoxamine (Luvox) produced a 63% response rate.
An older tricyclic antidepressant called clomipramine also affects serotonin and has shown a 65% response rate for BDD. It was tested head-to-head against desipramine (an antidepressant that works differently), which only achieved 35%. This comparison is one of the clearest pieces of evidence that serotonin activity specifically matters for BDD, not just antidepressant effects in general.
How These Medications Help
BDD involves repetitive, intrusive thoughts about perceived flaws in your appearance, along with compulsive behaviors like mirror-checking, skin picking, or seeking reassurance. SSRIs work by increasing the availability of serotonin in the brain, which dampens that obsessional loop. The thoughts don’t necessarily vanish, but they become less intense, less frequent, and easier to redirect.
This is why BDD responds to the same medications as OCD. Both conditions involve a cycle of obsessive thoughts and compulsive responses, and both improve when serotonin signaling is enhanced. There’s also evidence that these medications protect brain cells and may even promote the growth of new ones, which could contribute to longer-term recovery.
How Long Before You Notice a Change
BDD medication is not a fast fix. Most people need several weeks before they notice meaningful improvement. Research on therapy timelines found that the median time to first response was roughly 11 to 13 weeks, and reaching a full response could take 19 to 21 weeks. Medication timelines tend to follow a similar pattern: gradual improvement over months rather than days.
This slow onset can be discouraging, and it’s one of the main reasons people stop treatment too early. If you’ve been on an SSRI for three or four weeks without noticeable change, that’s expected. Most clinicians will trial a medication for at least 12 weeks at an adequate dose before considering it ineffective.
BDD Often Requires Higher Doses
One important distinction between treating BDD and treating straightforward depression is dosage. BDD typically requires doses at the higher end of the approved range, similar to what’s used for OCD. Your prescriber will generally start at a standard dose and increase gradually based on your response and how well you tolerate the medication. The side effects of SSRIs (which can include nausea, headaches, sleep changes, and sexual side effects) tend to be dose-dependent, so this gradual approach helps manage them.
When SSRIs Aren’t Enough
Between 27% and 47% of people don’t respond adequately to the first SSRI they try. In those cases, switching to a different SSRI is a common next step, since people who don’t respond to one may respond to another. Clomipramine is another option, though it tends to have more side effects than SSRIs.
Adding a low-dose antipsychotic medication to an SSRI is sometimes tried, particularly for people whose BDD includes delusional conviction (a firm belief that the perceived flaw is real and obvious to others, which affects roughly 35% to 50% of people with BDD). However, the evidence here is limited. In the only placebo-controlled study of antipsychotic augmentation for BDD, the antipsychotic wasn’t effective. Small case studies of olanzapine added to fluoxetine have shown mixed results, with only a minority of patients responding. This approach remains experimental rather than established.
Medication Combined With Therapy
Cognitive behavioral therapy is the other first-line treatment for BDD, and many clinicians recommend combining it with medication. CBT for BDD involves gradually confronting the situations you avoid because of appearance concerns, and learning to interrupt the compulsive behaviors that keep the obsessional cycle going. Medication can lower the intensity of intrusive thoughts enough to make therapy more effective, while therapy builds skills that medication alone doesn’t provide.
There isn’t robust head-to-head data comparing combined treatment to either one alone for BDD specifically. But the clinical consensus, drawn from both BDD research and the closely related OCD literature, is that the combination tends to produce better and more durable results than either approach by itself. For moderate to severe BDD, starting both simultaneously is a reasonable approach. For milder cases, some people do well with one or the other.
What “Response” Actually Means
When studies report a 53% to 73% response rate, they’re measuring a meaningful reduction in symptom severity on standardized scales. That doesn’t mean symptoms disappear entirely. A good medication response typically means the preoccupation with your appearance becomes less consuming, the urge to check or seek reassurance weakens, and you’re able to function better in daily life. Some people experience near-complete relief; others find that medication takes the edge off enough for them to engage with therapy and build a life that isn’t organized around their appearance concerns.
Relapse is common if medication is stopped abruptly. Most guidelines suggest continuing treatment for at least a year after symptoms improve, and some people benefit from staying on medication long-term. If you and your prescriber decide to taper off, doing so slowly and with a plan in place reduces the risk of symptoms returning.